Hyalo Technologies Limited Liability Company
FDA 503B outsourcing facility
Somerset, New Jersey
Key Takeaways
- FDA-registered 503B outsourcing facility since 2025
- Sterile compounding from bulk substances: Yes
- Not yet inspected by the FDA
About this facility
A 503B outsourcing facility is registered with the FDA under the Drug Quality and Security Act and may compound sterile medications in bulk without patient-specific prescriptions, under cGMP manufacturing standards. How federal compounding status works.
FDA registration and inspection record
- First registered with FDA
- May 1, 2025
- Most recent registration
- December 3, 2025
- Compounds sterile drugs from bulk substances
- Yes
- Last FDA inspection
- Not yet inspected
Hyalo Technologies Limited Liability Company has registered with the FDA as a 503B outsourcing facility but has not yet been inspected. The FDA inspects registered facilities on a risk-based schedule once drug production and distribution are confirmed.
Compounded peptides and GLP-1s
Hyalo Technologies Limited Liability Company has not assigned NDCs or filed product reports in the most recent FDA reporting periods. 503B outsourcing facilities are a primary supply route for compounded peptides and GLP-1s during FDA-listed shortages; PeptideGrids grades the evidence for each, including Semaglutide, Tirzepatide, BPC-157, Retatrutide. Browse the GLP-1 and therapeutic peptide databases.
Contact
FDA-registered contact: Shalabh Jain, 1-908-399-3600. Source: the facility's FDA outsourcing registration.
License verification
503B outsourcing facilities are also licensed by the state board of pharmacy. Verify the current license status of Hyalo Technologies Limited Liability Company with the New Jersey Board of Pharmacy.
503B facilities in New Jersey
New Jersey has 10 FDA-registered 503B outsourcing facilities in the PeptideGrids directory. See all 503B facilities in New Jersey.
Frequently asked questions
Is Hyalo Technologies Limited Liability Company registered with the FDA?
Yes. Hyalo Technologies Limited Liability Company is a registered 503B outsourcing facility, first registered with the FDA on May 1, 2025 and most recently registered on December 3, 2025.
Has Hyalo Technologies Limited Liability Company been inspected by the FDA?
Hyalo Technologies Limited Liability Company has registered with the FDA but has not yet been inspected as a 503B outsourcing facility.
Has Hyalo Technologies Limited Liability Company had any FDA drug recalls?
No FDA drug recalls are matched to Hyalo Technologies Limited Liability Company in the openFDA enforcement database.
What does Hyalo Technologies Limited Liability Company compound?
Hyalo Technologies Limited Liability Company has not filed product reports with NDC-assigned drugs in the most recent FDA reporting periods.
Where is Hyalo Technologies Limited Liability Company located?
Hyalo Technologies Limited Liability Company is located in Somerset, New Jersey.
Registration and inspection data verified against the FDA list of registered outsourcing facilities on June 6, 2026.
PeptideGrids is independent and not affiliated with, endorsed by, or sponsored by Hyalo Technologies Limited Liability Company. Listings, registration, inspection, and recall data are reported from public FDA records for informational purposes only. A recall or inspection finding is not an accusation of current wrongdoing. This is not medical or legal advice. To request a correction, see our corrections policy.